Treatment of advanced refractory lymphoma with teniposide and lomustine

Cancer Treat Rep. 1987 Feb;71(2):215-6.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Drug Evaluation
  • Female
  • Humans
  • Lomustine / administration & dosage
  • Lymphoma / drug therapy*
  • Lymphoma / pathology
  • Male
  • Middle Aged
  • Teniposide / administration & dosage

Substances

  • Lomustine
  • Teniposide